Novartis at PEGS Europe 2026
Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website
Novartis brings 8 presentations to PEGS Europe 2026 in Lisbon. Its program centres on the analytical characterisation, stability and formulation of biologics, with attention to high-dose and non-aqueous suspension products. Other topics include potency assay design for complex biologics and in silico optimisation of antibody-oligonucleotide conjugates.
| Organization | PEGS Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company with a large biologics pipeline across oncology, immunology, cardiovascular and neuroscience. | Talk Tue Nov 17 9:30am–10:00am Chair Tue Nov 17 2:00pm–2:05pm Chair Wed Nov 18 8:25am–8:30am Talk Wed Nov 18 9:00am–9:30am Talk Wed Nov 18 6:00pm–6:30pm Talk Thu Nov 19 8:30am–9:00am Chair Thu Nov 19 2:00pm–2:05pm Panel Thu Nov 19 3:35pm–4:15pm |
Instantly find 20 buyers from Novartis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction